(+)NAPROXEN

PharmaFlow in October: Deal making picks up; Pharma companies invest in capacity building

The year 2018 has witnessed a record-setting pace in approvals of new drugs. By early November, th

Trumpcare receives a blow; EMA to suspend 300 drugs due to clinical data integrity violations in India

This week, Phispers takes you to the US, where President Trump’s efforts to repeal and replace

Sanofi’s rough week; Quality snags at Pfizer; FDA warns against commonly used drug

This week, Phispers delves into Pfizer’s acquisition of Medivation and its impact on Sanofi. T